“What we’d like to do is triage all gynaecological disease – so when someone comes in with a complaint, can we give doctors a tool that quickly tells them it’s more likely to be a cancer or not, or this cancer than that.” -Daniel Heller
Building Novel Solutions for Women's Health
Leading Dutch and U.S. companies are joining forces to develop groundbreaking diagnostic tools and treatments in gynecological health.
The collaboration is supported by the Netherlands Innovation Network in Boston - Dutch Ministry of Economic Affairs.
Nine Diagnostics is proud to announce its acceptance into the latest cohort of the Merck Digital Sciences Studio (MDS Studio), a digital accelerator designed to enable the next generation of technologies for drug discovery and development, including artificial intelligence and machine learning. MDS Studio was founded to offer support for early-stage biomedical startups providing strategic guidance, direct investment, and connection opportunities within Merck.
Nine Diagnostics Selected for Merck Digital Sciences Studio Cohort 3 - Nine Diagnostics
Nine Diagnostics, a leader in cutting-edge medical diagnostics, is honored to announce that it has been awarded the Novo Nordisk Golden Ticket for a residency at LabCentral, hosted by the Novo Nordisk Bio Innovation Hub. This incredible opportunity is a significant milestone for the company, reinforcing its commitment to improving healthcare through advanced technologies that enable faster, more personalized diagnostics.
Nine Diagnostics Wins Novo Nordisk Golden Ticket for LabCentral Residency - Nine Diagnostics
Functional Precision Medicine by Design
Determining treatment effectiveness, discovering new biology using AI enabled nanosensor technology.